Medicine Overview of Bivasave Injection
Bivasave 250mg Injection is used for heart attack
and unstable angina.
It is also used in patients undergoing surgery to treat blockages in their blood vessels (angioplasty).
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Bivasave 250mg Injection is an anticoagulant that prevents the formation of harmful blood clots.
In Depth Information on Bivasave Injection
- Regularly check for any signs and symptoms of bleeding and allergy during the treatment with bivalirudin.
- Inform your doctor if you have been previously been treated with bivalirudin or similar medicines like lepirudin.
- Inform your doctor if you are undergoing radiation treatment in the vessels that supply blood to the heart (treatment called beta or gamma brachytherapy).
- You may require hospital stay of at least 24 hours for monitoring any signs and symptoms leading to serious cardiac events.
- Before you take bivalirudin, inform your doctor if you suffer from liver/kidney/heart problems.
- Inform your doctor if you are taking other blood thinners or medicines to prevent blood clots.
- Tell your doctor if you are or planning to become pregnant or are breastfeeding.
Bivasave Injection related warnings
Interaction with alcohol is unknown. Please consult your doctor.
Bivasave 250mg Injection is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Bivasave 250mg Injection is probably unsafe to use during la
Limited human data suggest that the drug could represent a significant risk to the baby.
Not relevant, as Bivasave 250mg Injection is intended for use in hospitalised patients.
Bivasave 250mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Bivasave 250mg Injection may be needed. Please consult your doctor.
Use of Bivasave 250mg Injection is not recommended in patients with severe kidney disease and patients undergoing dialysis.
Bivasave 250mg Injection is probably safe to use in patients
with liver disease. Limited data available suggests that dose adjustment of Bivasave 250mg Injection may not be needed in these patients. Please consult your doctor.
Frequently asked questions about Bivasave Injection
Bivasave is used to prevent the formation of blood clots in patients with chest pain due to heart disease (acute coronary syndromes - ACS) and who have undergone procedures to treat blockages in their blood vessels (angioplasty and/or percutaneous coronary intervention - PCI)
Bivasave is metabolized by enzymes called as proteases, which break down Bivasave into inactive products
Bivasave belongs to a class of drugs called parenteral anticoagulant, i.e. it is a blood-thinning agent that prevents formation of blood clots, and is administered by injection
Yes, Bivasave can cause increase in INR, which is a laboratory test to detect the ability of blood to clot. Increased INR indicates decreased clotting of blood
Bivasave increases the ACT, indicating reduced blood clotting ability
Bivasave acts by preventing the formation of clot in the blood vessels.
One of the following vendor pharmacies will deliver Bivasave 250mg Injection: MAX, PPR, GBL, SBA, OLT, DHR, PTI, EMB, NTB, GTC, DFP, SWA, SHD, PRN, VRS, HEX, ZVP, STA, SDM, BHP, ATP, DGN, OIP, AAR, IPL, WSI, PNT, JVO, ENP, AGT, DPL, LHA, MAK, PLT, FGH, RSS, MMS, NDP, OWP, GTK, DPP, NWP, BTM, USF, AAY, OHM, ADT, RKS, ABP, PVP, ARD, NSL, SWP, SCH, BMJ, MDO, SYN, WHL, RUS, BIO, 9T9, RPP, RJH, SAF, NNH, JIV, DLP, SSA, HMP, GPP, MSD, BAL, IAD, SVH, RHW, ANT, MPC, NVY, MOM, PEN, BSN, AMR, HBV, PWN, NXG, MLC, AVN, TRP, AYU, HAT, RSA, GNC, CLT, JMJ, BBS, KHH, TNH, EQN, HIP, UMP, HPC, NVL, SBL, DDR, DYG, GPT, MAM, RHL, BDN, RWP, THP, LCC, JVN, ATL, ZEL, SGC, SHP, INC, SJP, HGI, SAT